Shortcut Navigation:

Featured Clinical Trials

Learn what’s coming down the research pipeline, and find breast cancer clinical trials you may be eligible to participate in.

Participants With HER2-Negative, Metastatic Breast Cancer Sought for Vaccine Trial

Baltimore-based researchers seek participants with metastatic breast cancer for a phase II trial comparing a combination of chemotherapy plus a cancer vaccine with or without trastuzumab.

Vaccine Designed to Prevent or Delay Recurrence, Under Study

Researchers are recruiting 700 women with HER2-negative breast cancer for an international clinical trail assessing disease-free survival (DFS), the length of time during which participants show no signs of cancer, when treated with NeuVax, a cancer vaccine designed to prevent or delay disease recurrence.

Trial Compares Radiation Therapy Regimens Given After Lumpectomy

A study for women with early-stage breast cancer removed by lumpectomy compares the safety and effectiveness of a more rapid course of radiation with standard therapy.

Combination Treatment for HER2 Metastatic Cancer under Study

Researchers seek women with metastatic, HER2 positive breast cancer for a clinical trial that will test a new combination treatment. 

Trial Examines Treatment Combination for Metastatic Breast Cancer

Researchers seek women with ER positive, HER2 negative metastatic breast cancer for a clinical trial that will test letrozole in combination with a new medicine.

Phase III Trial Removes Primary Tumor in Metastatic Breast Cancer

A clinical trial seeks 880 participants to test whether removing the tumor in the breast in ­newly diagnosed metastatic breast cancer helps women who receive systemic therapy to live longer than those who receive systemic therapy alone. 

Observational Study Seeks Women with Metastatic HER2 Positive Breast Cancer

The new SystHERs (Systematic Therapies for HER2 positive Metastatic Breast Cancer Study) Registry seeks to enroll 1,000 people with HER2 positive metastatic breast cancer to analyze treatment patterns and outcomes. 

Trial Explores Anti-Estrogen Treatments and Chemotherapy

Researchers seek 4,000 participants for a clinical trial that will study whether hormonal therapy alone is adequate treatment for early-stage invasive breast cancer that traveled to one to three axillary lymph nodes and is found to be of low or intermediate risk for recurrence by genomic tests. 

Women Diagnosed Before 50 Needed for Study of Immune Response to Breast Cancer

A research study on immune response and suppression in different types of breast cancer seeks women diagnosed between the ages of 18 and 49 anywhere in the U.S.

Study of Ovarian Failure Needs Newly Diagnosed Young Women

Premenopausal women who are newly diagnosed with breast cancer and have not yet had chemotherapy are needed to participate in a study looking at biological factors that may relate to ovarian insufficiency after chemotherapy.